Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent
11/03/2026 09:59
March 11 (Reuters) - Elicera Therapeutics AB ELIC.ST: RECEIVES NOTICE OF ALLOWANCE FOR JAPANEASE PATENT PROTECTING THE ELC-401 CAR T-CELL CANDIDATE ONCE PATENT HAS BEEN GRANTED, IT CAN BE MAINTAINED IN FORCE UNTIL 2041 Source text: ID:nWkrnR9KH Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent